Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 1, 2000, Pages 230-243

  Taomoto, Makoto ^a   McLeod, D Scott ^a   Merges, Carol ^a   Lutty, Gerard A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCEROL 3 PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA DEVELOPMENT; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA;

ANIMALS; ANIMALS, NEWBORN; DENSITOMETRY; DISEASE MODELS, ANIMAL; DOGS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+); GLYCEROLPHOSPHATE DEHYDROGENASE; HISTOCYTOCHEMISTRY; HUMANS; HYPEROXIA; IMMUNOENZYME TECHNIQUES; INFANT, NEWBORN; OXYGEN; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; RETINA; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; VON WILLEBRAND FACTOR;

EID: 0033986514     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Snyder SH. Adenosine as a neuromodulator. Annu Rev Neurosci. 1985;8:103-124.
2. Sebastiao AM, Ribeiro JA. Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol. 1996;48:167-189.
3. Berne R, Knabb R, Ely SW, Rubio R. Adenosine in the local regulation of blood flow: a brief overview. Fed Proc. 1983;42: 3136-3142.
4. Phillis JW. Adenosine in the control of cerebral circulation. Cerebrovasc Brain Metab Rev. 1989;1:26-54.
5. Braunagel SC, Xiao JG, Chiou GCY. The potential role of adenosine in regulating blood flow in the eye. J Ocul Pharmacol. 1988;4:61-73.
6. Campochiaro PA, Sen HA. Adenosine and its agonists cause retinal vasodilation and hemorrhages. Arch Ophthalmol. 1989;107:412-416.
7. Gidday JM, Park TS. Microcirculatory responses to adenosine in the newborn pig. Pediatr Res. 1993;33:620-627.
8. Gidday JM, Park TS. Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet. Invest Ophthalmol Vis Sci. 1993;34: 2713-2719.
9. Roth S. Post-ischemic hypcremia in the cat retina: the effects of adenosine receptor blockade. Curr Eye Res. 1995;14:323-328.
10. Zhu Y, Gidday JM. Hypoglycemic hyperemia in retina of newborn pig: mediation by adenosine. Invest Ophthalmol Vis Sci. 1996;37: 86-92.
11. Teuscher E, Weidlich V. Adenosine nucleotides, adenosine and adenine as angiogenesis factors. Biomed Biochim Acta. 1985;44: 493-495.
12. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol. 1988;255:H554-H562.
13. Dusseau JW, Hutchins FM, Malbasa DS. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res. 1986;59:163-170.
14. Lutty G, Kunz M, Merges C, McLeod D. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res. 1998;17:594-607.
15. McLeod DS, Lutty GA, Wajer SD, Flower RW. Visualization of a developing vasculature. Microvasc Res. 1987;33:257-269.
16. Flower RW, McLeod DS, Lutty GA, Goldberg B, Wajer SD. Postnatal retinal vascular development of the puppy. Invest Ophthalmol Vis Sci. 1985;26:957-968.
17. Lutty GA, Merges C, McLeod DS. 5′ Nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 41:218-229.
18. McLeod DS, Brownstein R, Lutty GA. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 1996:37:300-311.
19. Collis M, Hourani S. Adenosine receptor subtypes. Trends Pharmacol Sci. 1993;14:360-366.
20. Kreutzberg G. Reddington M, Lee K, Schubert P. Adenosine: transport, function, and interaction with receptors in the CNS. J Neural Transm. 1983;18:113-119.
21. Poulsen SA, Quinn RJ. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem. 1998;6:619-641.
22. McLeod DS, Crone SN, Lutty GA. Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 1996;37:1322-1333.
23. McLeod DS, D'Anna SA, Lutty GA. Clinical and histopathological features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci. 1998;39:1918-1932.
24. Lutty G, Ikeda K, Chandler C, McLeod DS. Immunohistochemical localization of transforming growth factor-b in human photoreceptors. Curr Eye Res. 1991;10:61-74.
25. McLeod DS, Lutty GA. Menadione-dependent alpha glycerophosphate and succinate dehydrogenises in the developing canine retina. Curr Eye Res. 1995;14:819-826.
26. Ringler R, Singer T. Studies on mitochondrial GPDH. 1) Reaction of the dehyrodgenase with electron acceptors and the respiratory chain. J Biol Chem. 1959;234:2211-2217.
27. Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB. Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res. 1997;65:595-602.
28. Blazynski C. Discrete distributions of adenosine receptors in mammalian retina. J Neurochem. 1990;54:648-655.
29. Blazynski C, Perez M-TR. Neuroregulatory functions of adenosine in the retina. Prog Retinal Res. 1992;11:293-332.
30. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
31. Vials A, Burnstock G. A2-purinoreceptor-mediated relaxation in guinea pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993;109:424-429.
32. Li YO, Fredholm BB. Adenosine analogues stimulate cyclic AMP formation in rabbit cerebral microvessels via adenosine A2-receptors. Acta Physiol Scand. 1985;124:253-259.
33. Ibayashi S, Ngai AC, Meno JR, Winn HR. Effects of topical adenosine analogs and forskolin on rat pial arterioles in vivo. J Cereb Blood Flow Metab. 1990;11:72-76.
34. ATP channels mediate adenosine-induced hyperemia in retina. Invest Ophthalmol Vis Sci. 1996;37:2624-2633.
35. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:2165-2176.
36. Tuder RM, Karasek MA, Bensch KG. Cyclic adenosine munophusphate levels and the function of skin microvascular endothelial cells. J Cell Physiol. 1990;142:272-283.
37. Stelzner TJ, Weil JV, O'Brien RF. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties J Cell Physiol. 1989;139:157-166.
38. Pueyo ME, Chen Y, Michel JB. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp Cell Res. 1998;238:354-358.
39. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (FLT-1) that confers endothelial-specific gene expression. J Biol Chem. 1995;270: 27948-27953.
40. Chan-Ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that "physiological hypoxia" is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci. 1995;36:1201-1214.
41. Donahue ML, Phelps DL, Watkins RH, LoMonaco MB, Horowitz S. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen-induced retinopathy. Curr Eye Res. 1996;15:175-184.
42. Dorey CK, Aouididi S, Reynaud X, Dvorak H, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in rat. Arch Ophthalmol. 1996;114:1210-1217.
43. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
44. Fischer S, Sharma HS, Kaliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res. 1995;28:141-148.
45. Takagi H, King GL, Ferrara N, Aiello LP. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 1996;57:1311-1321.
46. Taomoto M, Witte L, McLeod DS, Merges CA, Zhu Z, Lutty GA. Vascular endothelial cell growth factor receptor-2 (KDR) in normal retinal vasculogenesis and canine oxygen-induced retinopathy (OIR) [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1999;40(4):S703. Abstract nr 3714.
47. Lewis CD, Hourani SM, Long CJ, Collis MG. Characterization of adenosine receptors in the rat isolated aorta. Gen Pharmac. 1994; 25:1381-1387.
48. Poucher SM, Keddie JR, Brooks R, Shaw GR, McKillup D. Pharmacodynamics of XM 241385, a potent A2a adenosine antagonist, after enteric administration in rat, cat and dog. J Pharm Pharmacol. 1996;48:601-606.
49. Sobrevia L, Yudilevich DL, Mann GE. Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in fetal human endothelial cells. J Physiol. 1997;499:135-140.
50. Mustafa SJ, Abebe W. Coronary vasodilation by adenosine-receptor subtypes and mechanism of action. Drug Dev Res. 1996;39:308-313.
51. Roth S, Rosenbaum PS, Osinski J, et al. Ischemia induces significant changes in purinc nucleoside concentration in the retina-choroid in rats. Exp Eye Res. 1997;65:771-779.
52. Li B, Rosenbaum PS, Jennings NM, Maxwell KA, Roth S. Differential roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Exp Eye Res. 1999;68:9-17.
53. Ongini E, Fredholm BB. Pharmacology of adenosine A2a receptors. Trends Pharmacol Sci. 1996;17:364-372.